Loading…
Loading…
ZPTA does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ZPTA and 80,000+ other tickers.
See exactly how ZPTA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ZPTA and 80,000+ other tickers.
Zapata Quantum, Inc. is a generative artificial intelligence firm. It utilizes sophisticated data science and engineering methodologies to devise solutions applicable on an industrial scale. The company was established in 2017 by Christopher Savoie, Alan Aspuru-Guzik, Yudong Cao, Jonathan Olson, Peter Johnson, and Jonathan Romero-Fontalvo, and its headquarters are located in Boston, Massachusetts.
The partnership combines QuEra's fault-tolerant hardware roadmap with Zapata's application intelligence expertise to bridge the quantum applications gap The partnership combines QuEra's fault-tolerant hardware roadmap with Zapata's application intelligence expertise to bridge the quantum applications gap
Zapata Quantum (OTCMKTS:ZPTA - Get Free Report) was up 7.3% on Monday. The stock traded as high as $0.92 and last traded at $0.88. 40,756 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 108,062 shares. The stock had previously closed at $0.82. Zapata Quantum Trading Up
Zapata Quantum OTCMKTS: ZPTA Chief Executive Officer Sumit Kapur used a presentation at the OTC Markets Global Technology Conference to argue that quantum computing is moving from a hardware-focused phase toward one in which software and applications will determine much of the sector's value.
CEO Sumit Kapur will discuss highlights including the Company's NVIDIA collaboration and quantum cancer research recognized as a Nature Biotechnology Top 10 CEO Sumit Kapur will discuss highlights including the Company's NVIDIA collaboration and quantum cancer research recognized as a Nature Biotechnology Top 10
Initiative targets the creation of a scalable automated system for quantum resource estimation, a major bottleneck in quantum application development Initiative targets the creation of a scalable automated system for quantum resource estimation, a major bottleneck in quantum application development